S&P 500 Futures Decline in Premarket Trading; Vaxcyte, PTC Lead

Dow Jones
1 hour ago

This article was automatically generated by Barrons.com using technology from Automated Insights.

With U.S. stock markets set to open in two hours, Vaxcyte Inc. $(PCVX)$ was up 54.1% in pre-market trading, and PTC Inc. (PTC) was up 36.2%.

Bio-Rad Laboratories Inc. Cl A (BIO), XP Inc. Cl A (XP), and Nu Holdings Ltd. Cl A (NU) were all posting gains of at least 11%. In early trading, Watts Water Technologies Inc. Cl A (WTS) and Westlake Corp. $(WLK)$ had posted declines, falling 13.0% and 11.2%, respectively.

Meanwhile S&P 500 futures were down 0.07%, with futures for the Dow Jones Industrial Average falling 0.06%. The Cboe Volatility Index futures were down 1.93%.

In commodities news, Brent crude oil futures were up 0.12%, while gold futures were up 0.65%. Bitcoin climbed 0.68% to $86,005.

The 10-Year Treasury yield slipped to 5.262%.

In the previous regular trading session, the S&P 500 and the Dow were up 0.73% and 0.49%, respectively. In Asia overnight, Japan's NIKKEI 225 Index was up 2.40%.

In afternoon trading, stocks in Europe are up, with the STOXX Europe 600 Index rising 0.32% and the FTSE 100 Index climbing 0.29% from the previous close.

U.S. stock markets open for trading at 9:30 a.m. ET.

Data source: Dow Jones Market Data, FactSet. Data compiled October 05, 2026.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10